The Schall Law Firm is handling a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged securities law violations between January 3, 2024, and December 2, 2024. The company is accused of making false statements and failing to follow proper clinical trial protocols for its drug candidate, govorestat, risking FDA rejection of its data. Shareholders who suffered losses can join the case by February 18, 2025.